A subpopulation of human B lymphocytes can express a functional Tissue Factor in response to phorbol myristate acetate

Houria Mechiche; Pascale Cornillet-Lefebvre; Philippe Nguyen

doi:10.1160/TH04-12-0845

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2005; 94(01): 146-154
DOI: 10.1160/TH04-12-0845

Platelets and Blood Cells

Schattauer GmbH

A subpopulation of human B lymphocytes can express a functional Tissue Factor in response to phorbol myristate acetate

Autoren

Houria Mechiche

¹Laboratoire Central d’Hématologie, CHU de Reims, and UPRES EA 3796, IFR53, Faculté de Médecine et de Pharmacie, Reims, France
Pascale Cornillet-Lefebvre

¹Laboratoire Central d’Hématologie, CHU de Reims, and UPRES EA 3796, IFR53, Faculté de Médecine et de Pharmacie, Reims, France
Philippe Nguyen

¹Laboratoire Central d’Hématologie, CHU de Reims, and UPRES EA 3796, IFR53, Faculté de Médecine et de Pharmacie, Reims, France

Abstract

Summary

Tissue Factor (TF, CD142) is a transmembrane glycoprotein that belongs to the cytokine receptor superfamily. This multifunctional protein is constitutively present in most tissues. Among circulating blood cells, TF expression is known to be restricted to monocytes which do not constitutively produce TF but express TF in response to various stimuli. Here, we report that highly purified B lymphocytes can support a procoagulant activity (PCA) in response to phorbol myristate acetate (PMA).Using flow cytometry (FCM), we observed that a subpopulation of B lymphocytes (CD19⁺) can expressTF and anionic phospholipids in response to PMA. TF protein was identified and characterized by immunofluorescence, immunocytochemistry and electronic microscopy. Using RT-PCR, we identified the presence of TF mRNA in response to PMA. In conclusion, B lymphocytes are a potential source of functional TF in human.

Keywords

Tissue factor - procoagulant activity - B lymphocyte - PMA

Volltext

Referenzen

References
1 Bazan JF. Structural design and molecular evolution of cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-8.
2 Edgington TS, Mackman N, Korbinian K. et al. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79.
3 Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-4.
4 Drake TA, Morrissey JH, Edgington TA. Selective cellular expression of tissue factor in human tissues: implication for disorders of haemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97.
5 Edwards RL, Rickles FR, Cronlund M. Abnormalities of blood coagulation in patient with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med 1981; 98: 917-28.
6 Osterud B, Bjorklid E. The production and availability of tissue factor thromboplastin in cellular populations on whole blood exposed to various concentration of endotoxin. An assay for detection of endotoxin. Scan J Haematol 1982; 29: 175-84.
7 van der Logt CP. et al. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysacccharide and phorbol ester. Blood Coagul Fibrinolysis 1994; 5: 211-20.
8 Rivers PRA, Hathaway WE, Weston WL. The endotoxin- induced coagulant activity of human monocytes. Br J Haematol 1975; 30: 311-6.
9 Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 9: 2752-5.
10 Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
11 Wilcox JN. et al. Localisation of tissue factor in normal vessel wall in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43.
12 Kato K, Elsayed YA, Namoto M. et al. Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits. Thromb Res 1996; 82: 335-47.
13 Levi M, ten Cate H, van der Poll T. et al. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270: 975-9.
14 Iijima K, Fukuda C, Nakamura K. Measurements of tissue factor-like activity in plasma of patients with DIC. Thromb Res 1991; 61: 29-38.
15 Giesen PLA, Rauch U, Bohrmann B. et al. Bloodborne tissue factor : another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
16 Imamura T, Kaneda H, Nakamura S. New functions of neutrophils in the arthus reaction: expression of tissue factor, the clotting initiator, and fibrinolysis by elastase. Lab Invest 2002; 82: 1287-95.
17 Todoroki H, Nakamura S, Higure A. et al. Neutrophils express tissue factor in a monkey model of sepsis. Surgery 2000; 127: 209-16.
18 Siddiqui FA, Desai H, Amirkhosravi A. et al. The presence and release of tissue factor from human platelets. Platelets 2002; 13: 247-53.
19 Garg SK, Niemetz J. Tissue factor activity of normal and leukemic cells. Blood 1973; 42: 729-35.
20 Rickles FR, Hair GA, Zeff RA. et al. Tissue factor expression in human leukocytes and tumor cells. Thromb Haemost 1995; 74: 391-5.
21 Goutner A, Beguin S, Josso F. Tissue factor activity of cultured human lymphocytes. Biomedecine 1975; 22: 298-302.
22 Edwards RL, Rickles FR. The role of human T cells (and T cell products) for monocyte tissue factor generation. J Immunol 1980; 125: 606-9.
23 Barrowcliffe TW. et al. Procoagulant activity of T lymphoblastoid cells in extrinsic and intrinsic coagulation systems. Thromb Haemost 1989; 62: 880-4.
24 Barrowcliffe TW, Fabregas P, Jardi M. et al. Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid. Thromb Haemost 2002; 87: 442-9.
25 Pickering W. et al. Characterization of the cell-surface procoagulant activity of T-lymphoblastoid cell lines. Thromb Haemost 2004; 2: 459-67.
26 Nguyen P, Broussas M, Cornillet-Lefebvre P. et al. Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation. Response of nonadherent cells to lipopolysaccharide. Transfusion 1999; 39: 975-82.
27 Dessen P, Fondrat C, Valencien C. et al. BISANCE: a French service for access to biomolecular sequence database. Comput Appl Biosci 1990; 6: 355-6.
28 Scaparti EM, Wen D, Broze GJ. et al. Human tissue factor : cDNA sequence and chromosome localization of the gene. Biochemistry 1987; 26: 5234-8.
29 Spicer EK. et al. Isolation of cDNA clones coding for human tissue factor :primary structure of the protein and cDNA. Proc Natl Sci USA 1987; 84: 5148-52.
30 van Deursen PBH. et al. A novel quantitative multiplex NASBA method: application to measuring tissue factor and CD14 mRNA levels in human monocytes. Nucleic Acids Res 1999; 27: 1-6.
31 Hollenbaugh D. et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182: 33-40.
32 Rauch U, Nemerson Y. Tissue factor, the blood and the arterial wall. Trends Cardiovasc Med 2000; 4: 139-43.
33 Rickles FR. et al. Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A. J Clin Invest 1973; 52: 1427-34.
34 Edwards RL, Rickles FR, Bobrove AM. Mononuclear cell tissue factor: cell of origin a requirements for activation. Blood 1979; 54: 359-70.
35 Chaby R, Metezeau P, Girard R. Binding of a rhodamine- labeled lipopolysaccharide to lipopolysaccharide- responder and nonresponder lymphocytes. Cell Immunol 1984; 85: 531-41.
36 Jacobs DM, Eldridge JH. Surface phenotype of LPS-binding murine lymphocytes. Proc Soc Exp Biol Med 1984; 175: 458-67.
37 Goodman SA, Morrison DC. Lipopolysaccharide receptors on lymphocytes. I. Lack of immunologic recognition of a putative LPS receptor on LPS-responder lymphocytes by LPS-nonresponder mice. J Immunol 1985; 135: 1906-10.
38 Kimura S, Tamamura T, Nakagawa I. et al. CD14– dependent and independent pathways in lipopolysaccharide- induced activation of a murine B-cell line, CH12.LX. Scand J Immunol 2000; 51: 392-9.
39 Zhou L. et al. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity. Thromb Haemost 1998; 79: 1025-8.
40 Sanguigni V. et al. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol 2005; 45: 35-42.
41 Randolph GJ. et al. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 1998; 92: 4167-77.
42 Poulsen LK, Jacobsen N, Sorensen BB. et al. Sal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem 1998; 273: 6228-32.
43 Broussas M. et al. Separation of dendritic cells from highly purified human monocytes by counterflow centrifugation induces tissue factor expression. Transfusion 2000; 40: 1088-94.